Abstract
To describe the efficacy of intravitreal chemotherapy (IViC) preceded by intra-arterial chemotherapy (IAC) for the treatment of advanced stage retinoblastoma. This non-comparative interventional case series retrospectively reviewed the medical records of six patients who presented within months of each other with unilateral retinoblastoma, Reese–Ellsworth stage Vb/D of ABC classification in the affected eye. After clinical and ophthalmoscopic evaluation, they underwent MRI to exclude local and CNS dissemination. The IAC was given to treat retinal masses and intravitreal injections to treat vitreous seeding. Patients had received two cycles (six infusions) of IAC, and from six up to ten melphalan injections into the vitreous, with an interval of 7–10 days between them. From one to four intravitreal injections were performed for partial remission or consolidation. No permanent complications of procedures have been reported. All patients underwent to bimonthly MRI examination, during treatment and every 3 months for 1 year after last injection, to exclude orbital dissemination. Successful control (100 %) of tumor masses and vitreous seeds was achieved in all cases at 12 months follow-up. Complications were posterior lens opacity, acute ischemic papillitis, partial CVR thrombosis, hypotonia (case 1), partial vitreous hemorrhage (case 4). No complications appeared in cases 2, 3, 5, and 6. No intraocular or orbital tumor recurrence or retinoblastoma metastases (follow-up range, 12–33 months) were observed. Sequential IAC and intravitreal melphalan for advanced retinoblastoma allowed to provide retinal and vitreous seed control.
References
Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP (2008) A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 115(8):1398–404, 1404.e1
Venturi C, Bracco S, Cerase A, Cioni S, Galluzzi P, Gennari P, Vallone IM, Tinturini R, Vittori C, De Francesco S, Caini M, D’Ambrosio A, Toti P, Renieri A, Hadjistilianou T (2013) Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments. Acta Ophthalmol 91(4):335–342
Abramson D, Marr B, Dunkel I et al (2012) Intra-arterial chemotherapy for retinoblastoma eyes with vitreous and/or subretinal seeding. Br J Ophthalmol 96:499–502
Sun YB, Hui P, Punyara K, Bi MC, Li SH, Teng SY, Song E (2013) Intravitreal injection of melphalan in the treatment of retinoblastoma with vitreous cavity seeding. Chin Med J (Engl) 126(8):1587
Ghassemi F, Shields CL (2012) Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma. Arch Ophthalmol 130(10):1268–1271
Munier FL, Gaillard MC, Balmer A, Beck-Popovic M (2013) Intravitreal chemotherapy for vitreous seeding in retinoblastoma: recent advances and perspectives. Saudi J Ophthalmol 27(3):147–150
Munier FL, Gaillard MC, Balmer A, Soliman S, Podilsky G, Moulin AP, Beck-Popovic M (2012) Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br J Ophthalmol 96(8):1078–1083
Shields CL, Manjandavida FP, Arepalli S, Kaliki S, Lally SE, Shields JA (2014) Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results. JAMA Ophthalmol 132(3):319–325
Smith SJ, Smith BD, Mohney BG (2014) Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review. Br J Ophthalmol 98(3):292–297
Munier FL, Soliman S, Moulin AP, Gaillard MC, Balmer A, Beck-Popovic M (2012) Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track. Br J Ophthalmol 96(8):1084–1087
Munier FL (2014) Classification and management of seeds in retinoblastoma. Ellsworth Lecture Ghent August 24th 2013. Ophthalmic Genet 35(4):193–207
Ong SJ, Chao AN, Wong HF, Liou KL, Kao LY (2014) Selective ophthalmic arteial injection of melphalan for intraocular retino blastoma: a 4 year review. Jpn J Ophthalmol 59(2):109–117
Acknowledgments
This study was funded by the AIGR/ONLUS Associazione Italiana Genitori Retinoblastoma and ITT (Istituto Tumori Toscana).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare they have no conflict of interest.
Research involving human and animal rights
Research does not involve Human Participants and/or Animals.
Rights and permissions
About this article
Cite this article
De Francesco, S., Galluzzi, P., Bracco, S. et al. Alternated intra-arterial and intravitreal chemotherapy for advanced intraocular retinoblastoma: preliminary successful results without systemic chemotherapy. Int Ophthalmol 35, 887–895 (2015). https://doi.org/10.1007/s10792-015-0129-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-015-0129-8